May 10th 2024
While Moderna expects mRNA-1345 to be approved later this month, the company cites FDA administrative constraints as reason for delay.
COVID-19 Vaccination Safe in Patients with Previous Myocarditis, According to New Research
March 17th 2022Adults with previous acute myocarditis did not experience recurrence or serious adverse events after COVID-19 vaccination in a small study presented at ESC Acute CardioVascular Care Congress 2022.